News
Video
Author(s):
Renowned oncologists discuss the case of a 75-year-old man with advanced renal cell carcinoma, providing insights into evaluation and frontline therapy choices.
Liso-Cel Elicits Consistent Responses in R/R CLL/SLL, Irrespective of High-Risk Features
Garcia-Manero on MDS Treatment Updates With Luspatercept and Beyond
Targeted Therapy, Vaccines, and Second-Generation Checkpoint Inhibitors Seek to Redefine mCRC Treatment
FDA Approval Insights: Durvalumab/Chemotherapy in dMMR Advanced Endometrial Cancer
Fruquintinib Represents a Novel Therapeutic Approach in Advanced mCRC
State of the Science Summit - Breast Cancer: Chaired by Christos Vaklavas, MD
Subcutaneous Rituximab Remains Underutilized in Non-Hodgkin Lymphoma
Dr Seymour on the Role of Mutational Profiling in CLL
Valemetostat Demonstrates Clinically Meaningful Efficacy in R/R PTCL